  | Streel, S.* , Salmon, A.* , DHEUR, A., Bours, V., LEROI, N., Habran, L., Delbecque, K., Goffin, F., PLEYERS, C., Kakkos, A., Gonne, E., Seidel, L., Kridelka, F.* , & Gennigens, C.*. (02 March 2023). Diagnostic Performance of Immunohistochemistry Compared to Molecular Techniques for Microsatellite Instability and p53 Mutation Detection in Endometrial Cancer. International Journal of Molecular Sciences, 24 (5), 4866. doi:10.3390/ijms24054866  Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Freire, M. V., MARTIN, M., Thissen, R., Van Marcke, C., SEGERS, K., SEPULCHRE, E., LEROI, N., LETE, C., FASQUELLE, C., Radermacher, J., Gokburun, Y., COLLIGNON, J., Sacré, A., JOSSE, C., PALMEIRA, L., & BOURS, V. (2022). Case Report Series: Aggressive HR Deficient Colorectal Cancers Related to BRCA1 Pathogenic Germline Variants. Frontiers in Oncology, 12, 835581. doi:10.3389/fonc.2022.835581 Peer Reviewed verified by ORBi |
 | LALLEMAND, F., LEROI, N., Blacher, S., Bahri, M. A., Balteau, E., COUCKE, P., Noël, A., Plenevaux, A., & Martinive, P. (2021). Tumor Microenvironment Modifications Recorded With IVIM Perfusion Analysis and DCE-MRI After Neoadjuvant Radiotherapy: A Preclinical Study. Frontiers in Oncology. doi:10.3389/fonc.2021.784437 Peer Reviewed verified by ORBi |
  | DOCAMPO MARTINEZ, E., MARTIN, M., GANGOLF, M., HARVENGT, J., BULK, S., SEGERS, K., LEROI, N., LETE, C., PALMARICCIOTTI, V., Freire Chadrina, M., LAMBERT, F., & Bours, V. (2021). Hérédité et cancer. Revue Médicale de Liège, 76 (5-6), 327-336. Peer reviewed |
 | Nagachinta, S., Becker, G., Dammicco, S., Serrano Navacerrada, M. E., LEROI, N., Bahri, M. A., Plenevaux, A., Lemaire, C., Lopez, R., Luxen, A., & de la Fuente, M. (2020). Radiolabelling of lipid-based nanocarriers with fluorine-18 for in vivo tracking by PET. Colloids and Surfaces B: Biointerfaces, 188, 110793. doi:10.1016/j.colsurfb.2020.110793 Peer Reviewed verified by ORBi |
 | Goux, M., Becker, G., Gorré, H., Dammicco, S., Desselle, A., Egrise, D., Leroi, N., Lallemand, F., Bahri, M. A., Doumont, G., Plenevaux, A., Cinier, M., & Luxen, A. (21 August 2017). Nanofitin as a New Molecular-Imaging Agent for the Diagnosis of 2 Epidermal Growth Factor Receptor Over-Expressing Tumors. Bioconjugate Chemistry, 28 (9), 2361-2371. doi:10.1021/acs.bioconjchem.7b00374 Peer Reviewed verified by ORBi |
 | Henry, A., Nokin, M.-J., Leroi, N., Lallemand, F., Lambert, J., Goffart, N., RONCARATI, P., BIANCHI, E., Peixoto, P., Blomme, A., Turtoi, A., Peulen, O., Habraken, Y., Scholtes, F., Martinive, P., Delvenne, P., Rogister, B., Castronovo, V., & Bellahcene, A. (2016). New role of osteopontin in DNA repair and impact on human glioblastoma radiosensitivity. Oncotarget. doi:10.18632/oncotarget.11483 Peer Reviewed verified by ORBi |
 | Leroi, N., LALLEMAND, F., COUCKE, P., Noël, A., & MARTINIVE, P. (30 March 2016). Impacts of Ionizing Radiation on the Different Compartments of the Tumor Microenvironment. Frontiers in Pharmacology, 7, 1-9. doi:10.3389/fphar.2016.00078 Peer Reviewed verified by ORBi |
 | Leroi, N., Sounni, N. E., Van Overmeire, E., Blacher, S., Marée, R., Van Ginderachter, J., Lallemand, F., LENAERTS, E., COUCKE, P., Noël, A.* , & MARTINIVE, P.*. (2015). The timing of surgery after neoadjuvant radiotherapy influences tumor dissemination in a preclinical model. Oncotarget. doi:10.18632/oncotarget.5931 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Suarez-Carmona, M., Bourcy, M., LESAGE, J., Leroi, N., Syne, L., Blacher, S., Hubert, P., Erpicum, C., Foidart, J.-M., Delvenne, P., Birembaut, P., Noël, A., Polette, M., & Gilles, C. (2015). Soluble factors regulated by epithelial-mesenchymal transition mediate tumour angiogenesis and myeloid cell recruitment. Journal of Pathology, 236 (4), 491-504. doi:10.1002/path.4546 Peer Reviewed verified by ORBi |
 | LALLEMAND, F., LEROI, N., Bahri, M. A., Balteau, E., Noël, A., Coucke, P., Plenevaux, A., & Martinive, P. (April 2019). Tumor modifications recorded with IVIM and DCE-MRI after Neoadjuvant radiotherapy. Radiotherapy and Oncology, 133 (Supplement 1), 284 - S285. doi:10.1016/S0167-8140(19)30960-0 Peer Reviewed verified by ORBi |
 | LALLEMAND, F., LEROI, N., Bahri, M. A., Balteau, E., Noël, A., Coucke, P., Plenevaux, A., & Martinive, P. (April 2018). Brain modifications after stereotactic radiotherapy recorded by Functional MRI. Radiotherapy and Oncology, 127 (Supplement 1), 582. doi:10.1016/S0167-8140(18)31346-X Peer Reviewed verified by ORBi |
 | LALLEMAND, F., LEROI, N., Bahri, M. A., Balteau, E., Noël, A., Coucke, P., Plenevaux, A., & Martinive, P. (April 2018). Tumor microenvironment modifications recorded with IVIM perfusion analysis after radiotherapy. Radiotherapy and Oncology, 127 (Supplement 1), 1285-S1286. doi:10.1016/S0167-8140(18)32640-9 Peer Reviewed verified by ORBi |
 | LALLEMAND, F., LEROI, N., Bahri, M. A., Balteau, E., Noël, A., Coucke, P., Plenevaux, A., & Martinive, P. (May 2017). Following tumour microenvironment after Neoadjuvant radiotherapy with IVIM perfusion analysis. Radiotherapy and Oncology, 123 (Supplement 1), 545. doi:10.1016/S0167-8140(17)31424-X Peer Reviewed verified by ORBi |
 | LALLEMAND, F., Leroi, N., Bahri, M. A., Balteau, E., Noël, A., COUCKE, P., MARTINIVE, P., & Plenevaux, A. (2016). Diffusion MRI for following tumor modifications after neoadjuvant radiotherapy. Radiotherapy and Oncology, 119, 966-S967. Peer Reviewed verified by ORBi |
 | LALLEMAND, F., Leroi, N., Bahri, M. A., Balteau, E., Noël, A., COUCKE, P., MARTINIVE, P., & Plenevaux, A. (April 2015). Functional MRI for predicting metastatic spreading at the time of surgery after neoadjuvant radiotherapy. Radiotherapy and Oncology, 115 (Supplement 1), 832-S833. doi:10.1016/S0167-8140(15)41518-X Peer Reviewed verified by ORBi |